Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 26 January 2021 to Question 141474, how many additional vaccine doses per month the expanded Vaccine Manufacturing Innovation Centre facility can produce as a result of the investment outlined in that Answer; and of which types of vaccine.

When fully operationally in 2022, the Vaccines Manufacturing and Innovation Centre (VMIC) will have several Good Manufacturing Process suites that will be able to accommodate a range of production scale capabilities. For pandemic response, the VMIC will be able to make up to 70 million doses of a vaccine within a 6-month timeframe. This is a significant increase to the VMIC’s originally anticipated capacity.

The VMIC has been designed to be a flexible manufacturing facility and will be able to manufacture a range of vaccine types, such as messenger RNA, viral vector, or protein sub-unit.